StockData
Jupiter Neurosciences, Inc. logo

Jupiter Neurosciences, Inc. (JUNS) stock

JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$1.70−0.06 (-3.41%)

Close on Nov 16, 2026Market cap $1.31MP/E –Yield –

Jupiter Neurosciences operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -40873.2%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-40873.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-11313.4%–
Q1 FY2026Mar 31, 2026-10524.3%–

More Jupiter Neurosciences figures

See a number that looks wrong?